MX2022005996A - Composiciones sensibles al ph, formulaciones, y métodos de imagenología de un tumor. - Google Patents
Composiciones sensibles al ph, formulaciones, y métodos de imagenología de un tumor.Info
- Publication number
- MX2022005996A MX2022005996A MX2022005996A MX2022005996A MX2022005996A MX 2022005996 A MX2022005996 A MX 2022005996A MX 2022005996 A MX2022005996 A MX 2022005996A MX 2022005996 A MX2022005996 A MX 2022005996A MX 2022005996 A MX2022005996 A MX 2022005996A
- Authority
- MX
- Mexico
- Prior art keywords
- formulations
- methods
- imagenology
- tumor
- sensitive compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
- A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/34—Esters containing nitrogen, e.g. N,N-dimethylaminoethyl (meth)acrylate
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0013—Luminescence
- A61K49/0017—Fluorescence in vivo
- A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
- A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
- A61K49/0032—Methine dyes, e.g. cyanine dyes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/001—Preparation for luminescence or biological staining
- A61K49/0063—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres
- A61K49/0069—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form
- A61K49/0076—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion
- A61K49/0082—Preparation for luminescence or biological staining characterised by a special physical or galenical form, e.g. emulsions, microspheres the agent being in a particular physical galenical form dispersion, suspension, e.g. particles in a liquid, colloid, emulsion micelle, e.g. phospholipidic micelle and polymeric micelle
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F220/00—Copolymers of compounds having one or more unsaturated aliphatic radicals, each having only one carbon-to-carbon double bond, and only one being terminated by only one carboxyl radical or a salt, anhydride ester, amide, imide or nitrile thereof
- C08F220/02—Monocarboxylic acids having less than ten carbon atoms; Derivatives thereof
- C08F220/10—Esters
- C08F220/38—Esters containing sulfur
- C08F220/382—Esters containing sulfur and containing oxygen, e.g. 2-sulfoethyl (meth)acrylate
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F293/00—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule
- C08F293/005—Macromolecular compounds obtained by polymerisation on to a macromolecule having groups capable of inducing the formation of new polymer chains bound exclusively at one or both ends of the starting macromolecule using free radical "living" or "controlled" polymerisation, e.g. using a complexing agent
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F299/00—Macromolecular compounds obtained by interreacting polymers involving only carbon-to-carbon unsaturated bond reactions, in the absence of non-macromolecular monomers
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
- G01N33/582—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with fluorescent label
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08F—MACROMOLECULAR COMPOUNDS OBTAINED BY REACTIONS ONLY INVOLVING CARBON-TO-CARBON UNSATURATED BONDS
- C08F2438/00—Living radical polymerisation
- C08F2438/01—Atom Transfer Radical Polymerization [ATRP] or reverse ATRP
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/70—Mechanisms involved in disease identification
- G01N2800/7023—(Hyper)proliferation
- G01N2800/7028—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Immunology (AREA)
- Hematology (AREA)
- Molecular Biology (AREA)
- Urology & Nephrology (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Organic Chemistry (AREA)
- Cell Biology (AREA)
- Biochemistry (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Inorganic Chemistry (AREA)
- Dispersion Chemistry (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Graft Or Block Polymers (AREA)
- Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
- Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
En la presente se describen formulaciones, métodos, y composiciones sensibles al pH útiles para la detección de tejidos tumorales primarios y metastásicos.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962937141P | 2019-11-18 | 2019-11-18 | |
| PCT/US2020/060910 WO2021101905A1 (en) | 2019-11-18 | 2020-11-17 | Ph responsive compositions, formulations, and methods of imaging a tumor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2022005996A true MX2022005996A (es) | 2022-10-27 |
Family
ID=75980983
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2022005996A MX2022005996A (es) | 2019-11-18 | 2020-11-17 | Composiciones sensibles al ph, formulaciones, y métodos de imagenología de un tumor. |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20230025280A1 (es) |
| EP (1) | EP4061428A4 (es) |
| JP (1) | JP7752110B2 (es) |
| KR (1) | KR20220149906A (es) |
| CN (1) | CN115279422B (es) |
| AU (1) | AU2020387279A1 (es) |
| BR (1) | BR112022009606A2 (es) |
| CA (1) | CA3158471A1 (es) |
| IL (1) | IL293101A (es) |
| MX (1) | MX2022005996A (es) |
| WO (1) | WO2021101905A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20220226511A1 (en) * | 2019-05-28 | 2022-07-21 | The Board Of Regents Of The University Of Texas System | pH RESPONSIVE COMPOSITIONS AND USES THEREOF |
| WO2025129124A1 (en) * | 2023-12-15 | 2025-06-19 | The Board Of Regents Of The University Of Texas System | Stimuli-responsive sting-activating polymer compositions and methods of use |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040253315A1 (en) * | 2001-07-13 | 2004-12-16 | Yasuaki Ogawa | Lyophilizing composition of drug-encapsulating polymer micelle and method for preparation thereof |
| CN103002921A (zh) * | 2010-05-14 | 2013-03-27 | 马林克罗特有限公司 | 用于联合的光学成像和治疗的功能性交联纳米结构 |
| DE102010022110A1 (de) * | 2010-05-31 | 2011-12-01 | LMU Universität München Department Chemie | Cyaninfarbstoffe als Kontrastmittel zur Unterstützung der Augenchirurgie |
| US9511152B2 (en) * | 2012-04-05 | 2016-12-06 | The Board Of Regents Of The University Of Texas System | Multicolored pH-activatable fluorescence nanoplatform |
| CN106573076A (zh) | 2014-06-06 | 2017-04-19 | 德克萨斯大学系统董事会 | pH响应聚合物库及其纳米探针 |
| CN104758247B (zh) * | 2015-04-22 | 2017-11-14 | 广东工业大学 | 一种pH响应聚合物混合胶束及其应用 |
| CA3016457A1 (en) | 2016-03-02 | 2017-09-08 | The Board Of Regents Of The University Of Texas System | Sting activating nanovaccine for immunotherapy |
| WO2018119476A1 (en) * | 2016-12-23 | 2018-06-28 | The Board Of Trustees Of The Leland Stanford Junior University | Activity-based probe compounds, compositions, and methods of use |
| US20200333357A1 (en) * | 2017-11-13 | 2020-10-22 | The Board Of Regents Of The University Of Texas System | Novel tfeb pathway agonists for metabolic diseases and ageing |
| CN108721649B (zh) * | 2018-06-26 | 2021-12-07 | 武汉凯德维斯生物技术有限公司 | 一种肿瘤靶向近红外荧光显像剂的设计、合成及应用 |
| US20220226511A1 (en) * | 2019-05-28 | 2022-07-21 | The Board Of Regents Of The University Of Texas System | pH RESPONSIVE COMPOSITIONS AND USES THEREOF |
-
2020
- 2020-11-17 IL IL293101A patent/IL293101A/en unknown
- 2020-11-17 US US17/756,190 patent/US20230025280A1/en active Pending
- 2020-11-17 BR BR112022009606A patent/BR112022009606A2/pt unknown
- 2020-11-17 CN CN202080093364.2A patent/CN115279422B/zh active Active
- 2020-11-17 EP EP20888772.9A patent/EP4061428A4/en active Pending
- 2020-11-17 KR KR1020227020259A patent/KR20220149906A/ko active Pending
- 2020-11-17 AU AU2020387279A patent/AU2020387279A1/en active Pending
- 2020-11-17 JP JP2022528615A patent/JP7752110B2/ja active Active
- 2020-11-17 MX MX2022005996A patent/MX2022005996A/es unknown
- 2020-11-17 WO PCT/US2020/060910 patent/WO2021101905A1/en not_active Ceased
- 2020-11-17 CA CA3158471A patent/CA3158471A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| KR20220149906A (ko) | 2022-11-09 |
| IL293101A (en) | 2022-07-01 |
| AU2020387279A1 (en) | 2022-06-02 |
| WO2021101905A1 (en) | 2021-05-27 |
| CA3158471A1 (en) | 2021-05-27 |
| EP4061428A4 (en) | 2023-12-20 |
| JP7752110B2 (ja) | 2025-10-09 |
| EP4061428A1 (en) | 2022-09-28 |
| CN115279422A (zh) | 2022-11-01 |
| US20230025280A1 (en) | 2023-01-26 |
| BR112022009606A2 (pt) | 2022-08-16 |
| JP2023502998A (ja) | 2023-01-26 |
| CN115279422B (zh) | 2024-03-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR112021024224A2 (pt) | Inibidores de tead e usos dos mesmos | |
| BR112021024108A2 (pt) | Inibidores de tead e usos dos mesmos | |
| PH12021500014A1 (en) | Fused ring compounds | |
| PH12021553018A1 (en) | New egfr inhibitors | |
| GEAP202215540A (en) | Pcsk9 antagonist compounds | |
| MX382562B (es) | Derivados pirrolidina espiro-condensados como inhibidores de enzimas desubiquitinantes (dub). | |
| IL285310A (en) | Detecting cancer, cancer tissue of origin, and/or a cancer cell typ | |
| BR112018016450A2 (pt) | composições intensificadoras de vcn e métodos de uso das mesmas | |
| MX2018016038A (es) | Compuestos y metodos para modular la funcion del acido ribonucleico (arn). | |
| AR119997A1 (es) | Anticuerpos anti-klk7, anticuerpos anti-klk5, anticuerpos multiespecíficos anti-klk5 / klk7 y métodos de uso | |
| BR112021016056A2 (pt) | Anticorpos de claudina 6 e usos dos mesmos | |
| MX2025010681A (es) | Formulaciones transdermicas | |
| MX384833B (es) | Inhibidores de tirosina quinasa de bruton | |
| MY197534A (en) | Anti-tryptase antibodies, compositions thereof, and uses thereof | |
| CL2022001452A1 (es) | Inhibidores de masp-2 y métodos de uso. | |
| MX2019011116A (es) | Inhibidores de la tirosina quinasa de bruton. | |
| MX388026B (es) | Compuestos y métodos para modular la tirosina cinasa de bruton. | |
| MX2023014154A (es) | Anticuerpos anti-ccr8. | |
| MX2021006515A (es) | Composiciones de methylobacterium para mejorar el rendimiento del maíz. | |
| EP4438127A3 (en) | Inhibiting ataxia telangiectasia and rad3-related protein (atr) | |
| MX2021003456A (es) | Spodoptera frugiperda resistente a proteina insecticida vegetativa 3a (vip3a). | |
| IL288856A (en) | Compositions, kits, methods and uses for preventing microbial growth | |
| MX2022005996A (es) | Composiciones sensibles al ph, formulaciones, y métodos de imagenología de un tumor. | |
| MX2020008076A (es) | Compuesto farmaceutico, sales del mismo, formulaciones del mismo y metodos para hacer y usar el mismo. | |
| MX2022006312A (es) | Inhibidores del receptor de hidrocarburos de arilo (ahr) y usos de los mismos. |